3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Status
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
7
Gastrointestinal
3
Conditions
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
1
Lung Neoplasms
1
Interventions
Oxaliplatin
297
Fluorouracil
272
Bevacizumab
235
Gemcitabine
234
Leucovorin
212
Capecitabine
204
pembrolizumab
200
Nivolumab
157
Irinotecan
156
Cisplatin
148
Specimen Handling
143
Magnetic Resonance Spectroscopy
130
130-nm albumin-bound paclitaxel
115
Paclitaxel
109
durvalumab
104
Cetuximab
102
Radiotherapy
96
atezolizumab
92
Biopsy
92
Drug Therapy
91
Albumin-Bound Paclitaxel
78
tislelizumab
77
Taxes
73
Folfox protocol
68
lenvatinib
67
Carboplatin
65
regorafenib
60
Blood Specimen Collection
60
trifluridine tipiracil drug combination
52
Ipilimumab
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
JDQ443
×
Gastrointestinal
×
1 year
×
Clear all
NCT05358249
2026-04-14
KontRASt-03
Novartis
Phase 1/2
Active not recruiting
74 enrolled
NCT07468071
2026-04-02
KontRASt-R
Novartis
Phase 1/2
Not yet recruiting
40 enrolled
NCT04699188
2026-03-18
KontRASt-01
Novartis
Phase 1/2
Active not recruiting
344 enrolled